Clinical Trial 37904


Chesterfield, MO 63005

Study Summary:

A Phase 2, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for the treatment of neurobehavioral disinhibition including aggression, agitation, and irritability in patients with traumatic brain injury (TBI).

Qualified Participants Must:

• Have experienced at least one traumatic brain injury at least 6 months ago
• Have symptoms of aggression, agitation or irritability after injury
• Be between 18 and 75 years of age
• Have a caregiver able to attend all study visits
• Not live in a nursing home

Qualified Participants May Receive:

Compensation is available for time and travel

Study is Available At:

Clinical Research Professionals
17998 Chesterfield Airport Road
Ste. 100
Chesterfield, MO 63005
View Clinic Location


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.